Current available therapies and future directions in the treatment of malignant gliomas

by Annick Desjardins, David A Reardon, James J Vredenburgh
Published 2008-12-01

Everolimus and Bevacizumab in the Management of Recurrent, Progressive Intracranial NF2 Mutated Meningioma

by Vinay Mathew Thomas, Poorva Bindal, James J. Vredenburgh
Published 2019-01-01

Treatment of Recurrent Intracranial Hemangiopericytoma with SRC-Related Tyrosine Kinase Targeted Therapy: A Case Report

by Katherine B. Peters, Roger McLendon, Michael A. Morse, James J. Vredenburgh
Published 2010-04-01

Primary Meningeal Rhabdomyosarcoma

by Manisha Palta, Richard F. Riedel, James J. Vredenburgh, Thomas J. Cummings, Scott Green, Zheng Chang, John P. Kirkpatrick
Published 2011-01-01

A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma.

by John H Sampson, Robert J Schmittling, Gary E Archer, Kendra L Congdon, Smita K Nair, Elizabeth A Reap, Annick Desjardins, Allan H Friedman, Henry S Friedman, James E Herndon, April Coan, Roger E McLendon, David A Reardon, James J Vredenburgh, Darell D Bigner, Duane A Mitchell
Published 2012-01-01